Literature DB >> 7176461

Cyanide toxicity of sodium nitroprusside in therapeutic use with and without sodium thiosulphate.

V Schulz, R Gross, T Pasch, J Busse, G Loeschcke.   

Abstract

Sodium nitroprusside (SNP) as a mono-infusion was administered to 51 patients for periods of a few hours. A further group of 19 patients received SNP for periods of several days as a combination solution of SNP mixed with sodium thiosulphate. The concentrations of cyanide and of thiocyanate in the blood of all patients were measured. In seven of the patients the level of thiosulphate was also measured. Infusion of SNP on its own at levels exceeding 2 microgram/kg/min led to the rising of cyanide levels in the blood being proportional to dosage. Infusion of SNP mixed with thiosulphate showed no such accumulation of cyanide in any patient, irrespective of dosage level and duration. The efficacy at lowering blood pressure was fully maintained in the mixed infusion. The elimination half-life for thiosulphate was 16.5 min. Pharmacokinetic calculation of the rise in cyanide level showed that mono-infusions of 5-10 micrograms SNP/kg/min could within 5-10 h cause a life-threatening cyanide level in the blood. By contrast, mixed infusion of SNP together with thiosulphate, for which light-opaque syringes and tubing must be used, is a procedure free of danger and should become the technique of choice when therapeutically administering SNP in order to lower blood pressure.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7176461     DOI: 10.1007/bf01716244

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  35 in total

1.  The metabolic state of thiosulphate.

Authors:  T W SZCZEPKOWSKI; B SKARZYNSKI; M WEBER
Journal:  Nature       Date:  1961-03-25       Impact factor: 49.962

2.  Cardiovascular actions of sodium nitroprusside in animals and hypertensive patients.

Authors:  I H PAGE; A C CORCORAN; H P DUSTAN; T KOPPANYI
Journal:  Circulation       Date:  1955-02       Impact factor: 29.690

3.  The renal clearance of thiosulfate with observations on its volume distribution.

Authors:  A GILMAN; F S PHILIPS; E S KOELLE
Journal:  Am J Physiol       Date:  1946-06

4.  Properties of the transsulfurase responsible for conversion of cyanide to thiocyanate.

Authors:  J P SAUNDERS; W A HIMWICH
Journal:  Am J Physiol       Date:  1950-11

5.  In vitro production of cyanide in normal human blood and the influence of thiocyanate and storage temperature.

Authors:  B Ballantyne
Journal:  Clin Toxicol       Date:  1977-09       Impact factor: 4.467

6.  A dosage nomogram for sodium nitroprusside-induced hypotension under anesthesia.

Authors:  N W Lawson; D S Thompson; C L Nelson; J W Flacke; A B Seifen
Journal:  Anesth Analg       Date:  1976 Jul-Aug       Impact factor: 5.108

Review 7.  Use of sodium nitroprusside during anesthesia and surgery.

Authors:  J H Tinker; R F Cucchiara
Journal:  Int Anesthesiol Clin       Date:  1978

8.  Severe lactic acidosis in a case of nitroprusside resistance.

Authors:  M Mellino; D F Phillips
Journal:  Cleve Clin Q       Date:  1980

9.  Cyanide and thiocyanate concentrations following sodium nitroprusside infusion in man.

Authors:  C J Vesey; P V Cole; P J Simpson
Journal:  Br J Anaesth       Date:  1976-07       Impact factor: 9.166

10.  Determination of cyanide and nitroprusside in blood and plasma.

Authors:  F L Rodkey; H A Collison
Journal:  Clin Chem       Date:  1977-11       Impact factor: 8.327

View more
  8 in total

1.  Note of caution for the use of sodium nitroprusside in neonatal hypertension.

Authors:  Christian von Schnakenburg; Marcus Krüger
Journal:  Pediatr Nephrol       Date:  2004-08-25       Impact factor: 3.714

2.  Detoxification of cyanide in a new-born child.

Authors:  V Schulz; B Roth
Journal:  Klin Wochenschr       Date:  1982-05-17

3.  Stability of Sodium Nitroprusside and Sodium Thiosulfate 1:10 Intravenous Admixture.

Authors:  Lucas T Schulz; Edmund J Elder; Karen J Jones; Ashwanth Vijayan; Benjamin D Johnson; Joshua E Medow; Lee Vermeulen
Journal:  Hosp Pharm       Date:  2010-10-01

4.  Effects of nitric oxide and its congeners on sickle red blood cell deformability.

Authors:  Andrea M Belanger; Christian Keggi; Tamir Kanias; Mark T Gladwin; Daniel B Kim-Shapiro
Journal:  Transfusion       Date:  2015-04-23       Impact factor: 3.157

Review 5.  Clinical pharmacokinetics of nitroprusside, cyanide, thiosulphate and thiocyanate.

Authors:  V Schulz
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

Review 6.  Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.

Authors:  Graeme Eisenhofer; Graham Rivers; Alejandro L Rosas; Zena Quezado; William M Manger; Karel Pacak
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

7.  Bioavailability of cyanide after consumption of a single meal of foods containing high levels of cyanogenic glycosides: a crossover study in humans.

Authors:  Klaus Abraham; Thorsten Buhrke; Alfonso Lampen
Journal:  Arch Toxicol       Date:  2015-02-24       Impact factor: 5.153

Review 8.  Recent Developments in Nitric Oxide Donors and Delivery for Antimicrobial and Anti-Biofilm Applications.

Authors:  Wee Han Poh; Scott A Rice
Journal:  Molecules       Date:  2022-01-20       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.